Royal Philips, the world's leading medical technology company, announced on March 22 that SHZ partovi will replace Jeroen TAS as the chief innovation and strategy officer, officially join the Philips Executive Committee and report directly to Frans van Houten, the chief executive officer. The adjustment will take effect on July 1, 2021, according to the Internet.
It is worth noting that before joining Philips, partovi, the new chief innovation and strategy officer, was the global head of healthcare, life sciences and medical device business development at Amazon, responsible for Amazon's global marketing.
According to reports, partovi's career began in 1998. He once served as a neuroradiologist of the Barrow Neurological Institute, and has been engaged in clinical practice until 2013. Since then, partovi has worked for 20 years in the fifth largest medical system in the United States, dignity health, and joined Amazon in 2018.
On the same day, Philips also announced that Jeroen TAs, the former chief innovation and strategy officer, will continue to hold the post at Philips, and his future work direction is to guide digital projects.
In addition, rob Cascella, Philips' current head of strategic business development and former head of Philips' diagnosis and treatment department, will withdraw from the Executive Committee as planned, starting from April 1, 2021.
"Shez partovi brings a wealth of healthcare and informatics experience to Philips, which will be of great significance for us to accelerate our transformation into a solution leader and use in-depth clinical insight and big data analysis," said Frans van Houten, chief executive of Philips. Jeroen and rob have made valuable contributions to the transformation of our company. Jeroen has played a very important role in inspiring and implementing our digital health and healthcare informatics strategy, and rob has contributed a wealth of experience to successfully shape our diagnosis and treatment department. "